Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer
Haiwang Luo, Di Cao, Mei Ma, Xinyi Lu, Jing Wang. Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer. // International Journal of Pharmaceutics: X. – 2026. – DOI: 10.1016/j.ijpx.2026.100597. – URL: https://doi.org/10.1016/j.ijpx.2026.100597
Haiwang Luo, Di Cao, Mei Ma, Xinyi Lu, & Jing Wang (2026). Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer. International Journal of Pharmaceutics: X. https://doi.org/10.1016/j.ijpx.2026.100597
Haiwang Luo, et al. “Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer.” International Journal of Pharmaceutics: X, 2026. doi:10.1016/j.ijpx.2026.100597.
@article{Luo2026,
title = {Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer},
author = {Luo, Haiwang and Cao, Di and Ma, Mei and Lu, Xinyi and Wang, Jing},
journal = {International Journal of Pharmaceutics: X},
year = {2026},
doi = {10.1016/j.ijpx.2026.100597},
url = {https://doi.org/10.1016/j.ijpx.2026.100597}
}